Vascular Endothelial Growth Factor
New Vascular Endothelial Growth Factor Research from Beth Israel Deaconess Medical Center Outlined
Published in Cancer Weekly, January 24th, 2012
2012 JAN 24 -- Investigators discuss in "Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy" new findings in Vascular Endothelial Growth Factor. "Antivascular therapy directed against VEGF or its receptors (VEGFR) has been successful when administered at early stages of tumor vessel growth but is less effective when administered later. Tumor blood vessels are heterogeneous, so vessel subpopulations may differ in their requirements for tumor cell-secreted VEGF and in their susceptibility to anti-VEGF/VEGFR therapy," investigators in Boston, Massachusetts report.
"Human cancers contain several distinct blood vessel...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-01-24)
More Articles from Cancer Weekly
- Familial Cancer
Study Results from University of Melbourne Update Understanding of Familial Cancer - Translational Medicine
Study Data from University of Colorado Update Understanding of Translational Medicine - Lung Cancer
Study Results from Chinese University of Hong Kong Provide New Insights into Lung Cancer - Bowel Diseases
Studies in the Area of Bowel Diseases Reported from Cedars-Sinai Medical Center - Gastric Cancer
Studies from Yokohama City University Update Current Data on Gastric Cancer - Leukemia
Studies from University of Bari Reveal New Findings on Leukemia - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
